Who Priority: Pathogens List For R&d Of New Antibiotics //top\\

(e.g., Klebsiella pneumoniae , E. coli ) 3rd generation cephalosporin-resistant Enterobacterales Rifampicin-resistant Mycobacterium tuberculosis (RR-TB) 2. High Priority: High-Burden and Community Threats

(Added in 2024) 2. High Priority

This tier includes multi-drug resistant bacteria that are particularly dangerous in hospitals and nursing homes. They can cause life-threatening infections such as sepsis and pneumonia. who priority pathogens list for r&d of new antibiotics

Published by the , this list categorizes antibiotic-resistant bacteria into tiers to guide and prioritize research & development (R&D) of new antimicrobials. It was first released in 2017 and updated in 2024. who priority pathogens list for r&d of new antibiotics

The list serves as a roadmap for scientists, investors, and policymakers to focus on bacteria for which new treatments are most desperately needed. 1. Critical Priority who priority pathogens list for r&d of new antibiotics

(New standalone addition in 2024)